Silicon Laboratories Inc. (SLAB)
91.50
0.20 (0.22%)
At close: Apr 15, 2025, 3:59 PM
90.00
-1.64%
After-hours: Apr 15, 2025, 06:14 PM EDT
Silicon Laboratories Revenue Breakdown
| Period Ending | Sep 28, 2024 | Jun 29, 2024 | Dec 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 |
|---|---|---|---|---|---|---|
| Industrial & Commercial Revenue | 96.5M | 88.08M | 180.56M | 165.3M | 150.71M | 157.25M |
| Industrial & Commercial Revenue Growth | +9.55% | -51.22% | +9.23% | +9.68% | -4.16% | n/a |
Revenue by Geography
| Period Ending | Dec 30, 2023 | Dec 31, 2022 | Jan 1, 2022 | Dec 31, 2011 |
|---|---|---|---|---|
| China Revenue | 219.74M | 334.82M | 311.51M | 91.93M |
| China Revenue Growth | -34.37% | +7.48% | +238.86% | n/a |
| Rest Of World Revenue | 379.58M | 407.3M | 311.88M | n/a |
| Rest Of World Revenue Growth | -6.81% | +30.60% | n/a | n/a |
| Taiwan Revenue | 90.38M | 105.6M | 97.47M | n/a |
| Taiwan Revenue Growth | -14.41% | +8.34% | n/a | n/a |
| United States Revenue | 92.55M | 176.38M | n/a | n/a |
| United States Revenue Growth | -47.53% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Jan 1, 2022 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 | Jan 2, 2021 | Oct 3, 2020 | Jul 4, 2020 | Apr 4, 2020 | Dec 28, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 29, 2018 | Sep 29, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 30, 2017 | Sep 30, 2017 | Jul 1, 2017 | Apr 1, 2017 | Dec 31, 2016 | Oct 1, 2016 | Jul 2, 2016 | Apr 2, 2016 | Jan 2, 2016 | Oct 3, 2015 | Jul 4, 2015 | Apr 4, 2015 | Jan 3, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 36.41M | 36.79M | 38.68M | 33.53M | 33.63M | 27.77M | 40.71M | 44.89M | 46.57M | 50.74M | 49.01M | 44.65M | 53.49M | 46.13M | 42.95M | 51.95M | 50.46M | 48.48M | 48.4M | 54M | 50.87M | 47.72M | 48.64M | 49.22M | 48.95M | 49.41M | 53.8M | 45.69M | 40.14M | 39.61M | 39.83M | 40.16M | 38.77M | 38.03M | 39.05M | 39.64M | 41.5M | 35.73M | 40.96M | 42.3M | 39.53M |
| Selling, General, and Administrative Revenue Growth | -1.04% | -4.87% | +15.33% | -0.29% | +21.13% | -31.79% | -9.32% | -3.61% | -8.21% | +3.52% | +9.78% | -16.53% | +15.95% | +7.39% | -17.32% | +2.96% | +4.07% | +0.16% | -10.36% | +6.15% | +6.60% | -1.89% | -1.18% | +0.55% | -0.93% | -8.16% | +17.73% | +13.84% | +1.35% | -0.55% | -0.82% | +3.58% | +1.93% | -2.59% | -1.49% | -4.48% | +16.14% | -12.77% | -3.17% | +7.02% | n/a |
| Research and Development Revenue | 82.44M | 83.23M | 79.85M | 74.59M | 83.4M | 79.04M | 85.9M | 89.4M | 86.65M | 84.62M | 83.51M | 77.54M | 71.7M | 72.66M | 64.83M | 76.47M | 73.86M | 71.97M | 70.84M | 71.22M | 69.18M | 62.55M | 63.86M | 61.57M | 62.93M | 61.09M | 59.49M | 54.83M | 52.73M | 52M | 52.43M | 52.32M | 50.63M | 48.44M | 51.63M | 49.05M | 47.24M | 46.48M | 47.47M | 46.86M | 46.14M |
| Research and Development Revenue Growth | -0.95% | +4.23% | +7.05% | -10.57% | +5.52% | -7.99% | -3.91% | +3.17% | +2.39% | +1.33% | +7.70% | +8.14% | -1.31% | +12.07% | -15.22% | +3.54% | +2.62% | +1.60% | -0.54% | +2.96% | +10.59% | -2.04% | +3.72% | -2.17% | +3.02% | +2.68% | +8.51% | +3.97% | +1.41% | -0.82% | +0.21% | +3.35% | +4.52% | -6.19% | +5.28% | +3.81% | +1.64% | -2.07% | +1.30% | +1.56% | n/a |